Loading...

RXRX RECURSION PHARMACEUTICALS INC Earnings Reports 8-K Filing

RCRS

RXRX

RECURSION PHARMACEUTICALS INC

(RXRX)

2025 8-K

Summary

Summary

Acquisition Update

Financial Statements

Asset Acquisitions

Management Changes

Equity Offerings

Financial Statements

Board Appointments

Earnings Results

Investor Presentation

Stock Resale Registration

CFO Employment Agreement

Acquisition Update

Acquisition Details

Acquisition Completed

Acquisition Agreement

Acquisition Agreement

Q3 Financial Results

Acquisition Agreement

Acquisition Update

Acquisition Announcement

Acquisition Agreement

Public Offering

Press Release and Investor ...

Change in Registrant's Cert...

Results of Operations and F...

Appointment of Dr. Najat Kh...

Results of Operations and F...

Departure of Directors or C...

Bylaws Amendment

Regulation FD Disclosure

Partnership Agreement and I...

Master Agreement with Tempu...

Financial Results

Regulation FD Disclosure

Acquisition of Cyclica Inc.

Acquisition of Cyclica Inc.

Appointment, Acquisition

Earnings Reports

Regulation FD Disclosure

Financial Results Announcement

Management Changes

Investor Presentation

External Links:

On May 5, 2025, Recursion Pharmaceuticals, Inc. reported its financial results for the first quarter of 2025 and released an updated corporate presentation on their website. The filing includes important forward-looking statements and risk factors affecting the company.

AI Assistant

RECURSION PHARMACEUTICALS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.